1. Home
  2. TNGX vs PANL Comparison

TNGX vs PANL Comparison

Compare TNGX & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • PANL
  • Stock Information
  • Founded
  • TNGX 2014
  • PANL 1996
  • Country
  • TNGX United States
  • PANL United States
  • Employees
  • TNGX N/A
  • PANL N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • TNGX Health Care
  • PANL Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • PANL Nasdaq
  • Market Cap
  • TNGX 317.4M
  • PANL 278.6M
  • IPO Year
  • TNGX N/A
  • PANL N/A
  • Fundamental
  • Price
  • TNGX $1.10
  • PANL $4.07
  • Analyst Decision
  • TNGX Strong Buy
  • PANL Strong Buy
  • Analyst Count
  • TNGX 7
  • PANL 1
  • Target Price
  • TNGX $12.33
  • PANL N/A
  • AVG Volume (30 Days)
  • TNGX 542.7K
  • PANL 219.1K
  • Earning Date
  • TNGX 05-12-2025
  • PANL 05-12-2025
  • Dividend Yield
  • TNGX N/A
  • PANL 9.83%
  • EPS Growth
  • TNGX N/A
  • PANL 8.62
  • EPS
  • TNGX N/A
  • PANL 0.63
  • Revenue
  • TNGX $42,069,000.00
  • PANL $536,536,246.00
  • Revenue This Year
  • TNGX N/A
  • PANL $11.92
  • Revenue Next Year
  • TNGX N/A
  • PANL $14.14
  • P/E Ratio
  • TNGX N/A
  • PANL $6.46
  • Revenue Growth
  • TNGX 15.17
  • PANL 7.46
  • 52 Week Low
  • TNGX $1.11
  • PANL $3.93
  • 52 Week High
  • TNGX $12.02
  • PANL $8.32
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 33.44
  • PANL 40.88
  • Support Level
  • TNGX $1.38
  • PANL $3.95
  • Resistance Level
  • TNGX $1.56
  • PANL $4.21
  • Average True Range (ATR)
  • TNGX 0.16
  • PANL 0.13
  • MACD
  • TNGX -0.01
  • PANL 0.02
  • Stochastic Oscillator
  • TNGX 9.90
  • PANL 36.62

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: